The psychedelic drug DOI reduces heroin motivation by targeting 5-HT2A receptors in a heroin and alcohol co-use model.

MLA

Bonilla, Joel, et al. “The Psychedelic Drug DOI Reduces Heroin Motivation by Targeting 5-HT2A Receptors in a Heroin and Alcohol Co-Use Model.” Neuropharmacology, vol. 261, Dec. 2024, p. 110163. EBSCOhost, https://doi.org/10.1016/j.neuropharm.2024.110163.

APA

Bonilla, J., Giannotti, G., Kregar, N. P., Heinsbroek, J. A., Olson, D. E., & Peters, J. (2024). The psychedelic drug DOI reduces heroin motivation by targeting 5-HT2A receptors in a heroin and alcohol co-use model. Neuropharmacology, 261, 110163. https://doi.org/10.1016/j.neuropharm.2024.110163

Chicago

Bonilla, Joel, Giuseppe Giannotti, Nathaniel P Kregar, Jasper A Heinsbroek, David E Olson, and Jamie Peters. 2024. “The Psychedelic Drug DOI Reduces Heroin Motivation by Targeting 5-HT2A Receptors in a Heroin and Alcohol Co-Use Model.” Neuropharmacology 261 (December): 110163. doi:10.1016/j.neuropharm.2024.110163.